• United States -
    • English
    • Global
    • us
      United States
      English
    • Asia
    • zh.svg
      China - 中国
      简体中文 (Chinese) / English
    • Europe
    • de
      Germany
      Deutsch (German) / English
    • it
      Italy
      Italiano (Italian) / English
    • es
      Spain
      Español (Castilian Spanish) / English
    • uk
      United Kingdom
      English
    • North America
    • mx
      Mexico
      Español (Spanish) / English
    • us
      United States
      English
    • South America
    • ar
      Argentina
      Español (Spanish) / English
    • cl
      Chile
      Español (Spanish) / English
    • co
      Colombia
      Español (Spanish) / English
  • Customer Support
  • FLASH RT
    • Ultra-high Dose Rate (UHDR) FLASH Radiotherapy
    • FLASH-RT Clinical Studies
  • Electron RT for Skin Cancer
    • Electron Therapy for Skin Cancer
    • Sales Inquiries
  • IORT
    • Electron IORT Overview
    • Meet the Mobetron
    • Mobetron Treatment Locations
    • Pancreatic Cancer Treatment with Mobetron
    • Breast Cancer Treatment with Mobetron
    • Single-Fraction APBI with Mobetron
    • Boost with Mobetron
    • IORT Clinical Studies
    • Mobetron Clinical Studies
    • Customer Support
    • Sales Inquiries
  • Healthcare Professionals
    • Healthcare Professionals Overview
    • Dermatologists
    • Surgical Oncologists
    • Radiation Oncologists
    • Hospital Administrators
    • Insurance Companies
  • Patients
    • Cancer Patients + Families
    • Patient Success Stories
  • IntraOp
    • About IntraOp
    • News and Events
  • Contact
    • Contact IntraOp
    • Sales Inquiries
    • Customer Support
  • Home
  • FLASH Radiotherapy
    • Ultra-high Dose Rate (UHDR) FLASH Radiotherapy
    • FLASH-RT Clinical Studies
  • Electron Therapy for Skin Cancer
    • Electron Therapy for Skin Cancer
    • Sales Inquiries
  • Mobetron IORT
    • Electron IORT Overview
    • Mobetron Treatment Locations
    • Mobetron Clinical Studies
    • Pancreatic Cancer Treatment with Mobetron
    • Breast Cancer Treatment with Mobetron
    • Single-Fraction APBI with Mobetron
    • Boost with Mobetron
    • IORT Clinical Evidence
    • Customer Support
    • Sales Inquiries
  • Healthcare Professionals
    • Healthcare Professionals Overview
    • Dermatologists
    • Surgical Oncologists
    • Radiation Oncologists
    • Hospital Administrators
    • Insurance Companies
  • Patients
    • Cancer Patients + Families
    • Patient Success Stories
  • IntraOp
    • About IntraOp
    • News and Events
  • Contact
    • Contact IntraOp
    • Sales Inquiries
    • Customer Support
  • Global
  • us Corporate English
  • Asia
  • zh.svg China - 中国 简体中文 (Chinese) / English
  • Europe
  • de Germany Deutsch (German) / English
  • it Italy Italiano (Italian) / English
  • es Spain Español (Castilian Spanish) / English
  • uk United Kingdom English
  • North America
  • mx Mexico Español (Spanish) / English
  • us United States English
  • South America
  • ar Argentina Español (Spanish) / English
  • cl Chile Español (Spanish) / English
  • co Colombia Español (Spanish) / English

Emerging Cancer Indications: Skin

Home > Skin
Sorry, no results were found.

View Clinical research and studies by

  • Proven Cancer Indications
    • Breast (Boost)
    • Breast (Single-Fraction APBI)
    • Colorectal
    • Gynecological
    • Head and Neck
    • Pancreatic
    • Sarcoma
    • Skin
  • Emerging Cancer Indications
    • Brain
    • Esophageal
    • Gastric
    • Genitourinary
    • Lung
    • Pediatric
    • Prostate
    • Skin
    • Spinal Metastases
  • FLASH Radiotherapy
    • Electron-beam FLASH
IntraOp Corporate HQ

IntraOp Medical Corporation
448 Kato Terrace
Fremont CA 94539

+1 408.636.1020

Contact IntraOp
  • Customer Support
  • General Inquiries
  • Sales Inquiries
Latest News
  • On-Demand Webinar: IORT Advancements in Cancer Treatments
2025 © All rights reserved. IntraOp Medical, Inc.
  • Privacy and Terms
  • Sitemap